TRILOGY ACETABULAR CROSSLINKED LINER
Report
- Report Number
- 1822565-2011-01629
- Event Type
- Injury
- Date Received
- July 12, 2011
- Date of Event
- June 3, 2011
- Report Date
- June 15, 2011
- Manufacturer
- ZIMMER, INC.
- Product Code
- LPH
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IT
- Reporter Occupation
- PHYSICIAN
Narratives
EVAL SUMMARY: SURGICAL NOTES WERE NOT PROVIDED. X-RAYS WERE NOT PROVIDED; IT IS UNK WHETHER THE COMPONENTS WERE IMPLANTED WITH THE CORRECT FIT AND ORIENTATION AS PER THE SURGICAL TECHNIQUE. IN GENERAL, PT FACTORS THAT MAY AFFECT THE PERFORMANCE OF THE COMPONENTS INCLUDE: AGE, BONE QUALITY, HEIGHT/WEIGHT, ACTIVITY LEVEL, TYPE OF ACTIVITY (LOW IMPACT VS HIGH IMPACT), AND RELEVANT MEDICAL HISTORY. ADHERENCE TO REHABILITATION PROTOCOL IS UNK. THE PER INDICATED THAT THE LINER WAS IMPLANTED IN COMBINATION WITH NON-ZIMMER DEVICES WHICH IS NOT RECOMMENDED SINCE ZIMMER DEVICES HAVE NOT BEEN TESTED WITH NON-ZIMMER DEVICES. IT IS UNK IF THE USE OF NON-ZIMMER DEVICES IN COMBINATION WITH THE LINER CAUSED IT TO WEAR IN AN UNUSUAL MANNER. WITH THE INFO PROVIDED, IT IS UNK IF THE WEAR REPORTED ON THE LINER IS CONSISTENT WITH USE OVER 6 YEARS. A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED AT THIS TIME. THE MANUFACTURING RECORDS WERE REVIEWED AND FOUND TO BE CONFORMING INDICATING THAT THE LINER WAS MANUFACTURED, INSPECTED, AND PACKAGED TO SPECIFICATION. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY EVIDENCE OF PRODUCT CONTRIBUTION TO THE REPORTED PROBLEM. BASED ON THE INVESTIGATION, THE NEED FOR CORRECTIVE ACTION IS NOT INDICATED. SHOULD ADDITIONAL SUBSTANTIVE INFO BE RECEIVED, THE COMPLAINT WILL BE RE-OPENED. ZIMMER, INC CONSIDERS THIS COMPLAINT CLOSED.
IT IS REPORTED THAT THE PT WAS REVISED DUE TO THE ACETABULAR INSERT BEING WORN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TRILOGY ACETABULAR CROSSLINKED LINER | LPH | ZIMMER, INC. | 60239910 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 62 YR | Required Intervention |